Russell Investments Group
AVXL icon

Russell Investments Group’s Anavex Life Sciences AVXL Stock Holding History

Russell Investments Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.8K Buy
23,490
+17,150
+271% +$50.7K ﹤0.01% 3577
2026
Q1 		$19.5K Sell
6,340
-584
-8% -$2.53K ﹤0.01% 3632
2025
Q4 		$24.6K Sell
6,924
-60
-0.9% -$368 ﹤0.01% 3552
2025
Q3 		$62.2K Buy
6,984
+6,924
+11,540% +$70.2K ﹤0.01% 3190
2025
Q2 		$553 Buy
60
+22
+58% +$188 ﹤0.01% 3738
2025
Q1 		$326 Buy
+38
New +$359 ﹤0.01% 3713
2024
Q2 		– Sell
-115
Closed -$585 – 3582
2024
Q1 		$585 Buy
115
+29
+34% +$163 ﹤0.01% 3188
2023
Q4 		$801 Buy
+86
New +$592 ﹤0.01% 3083
2023
Q2 		– Sell
-41,007
Closed -$351K – 3452
2023
Q1 		$351K Hold
41,007
– – ﹤0.01% 2363
2022
Q4 		$380K Hold
41,007
– – ﹤0.01% 2377
2022
Q3 		$423K Hold
41,007
– – ﹤0.01% 2308
2022
Q2 		$410K Hold
41,007
– – ﹤0.01% 2330
2022
Q1 		$504K Hold
41,007
– – ﹤0.01% 2221
2021
Q4 		$711K Hold
41,007
– – ﹤0.01% 2315
2021
Q3 		$736K Sell
41,007
-96,766
-70% -$1.93M ﹤0.01% 2322
2021
Q2 		$3.15M Sell
137,773
-120,802
-47% -$1.79M 0.01% 1643
2021
Q1 		$3.86M Sell
258,575
-86,162
-25% -$941K 0.01% 1492
2020
Q4 		$1.86M Sell
344,737
-148,071
-30% -$780K ﹤0.01% 1797
2020
Q3 		$2.24M Buy
492,808
+277,381
+129% +$1.19M ﹤0.01% 1611
2020
Q2 		$1.06M Sell
215,427
-26,049
-11% -$98.4K ﹤0.01% 2021
2020
Q1 		$757K Buy
+241,476
New +$841K ﹤0.01% 1985
2017
Q4 		– Sell
-19,196
Closed -$79K – 2952
2017
Q3 		$79K Hold
19,196
– – ﹤0.01% 2804
2017
Q2 		$102K Hold
19,196
– – ﹤0.01% 2803
2017
Q1 		$110K Sell
19,196
-6,290
-25% -$32.5K ﹤0.01% 2799
2016
Q4 		$102K Buy
+25,486
New +$90.8K ﹤0.01% 2872

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Russell Investments Group's AVXL Position: Q2 2026 in Review

Russell Investments Group increased its Anavex Life Sciences (AVXL) stake by 271% in Q2 2026, buying an estimated $50.7K and bringing the position to 23,490 shares worth $60.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3577.

Russell Investments Group first reported a position in AVXL in Q4 2016 and has held it in 25 quarters since. The position peaked at $3.86M in Q1 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Russell Investments Group held 23,490 shares of Anavex Life Sciences worth $60.8K as of Q2 2026.
  • Russell Investments Group bought 17,150 Anavex Life Sciences shares in Q2 2026, an estimated $50.7K.
  • Anavex Life Sciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3577 holding.
  • Russell Investments Group first reported a position in Anavex Life Sciences in Q4 2016 and has held it in 25 quarters since.
  • Russell Investments Group's Anavex Life Sciences position peaked at $3.86M in Q1 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.